Highlights and Quick Summary
- Capex/Depreciation for the quarter ending September 30, 2023 was -0.08 (a 54.4% increase compared to previous quarter)
- Year-over-year quarterly Capex/Depreciation decreased by -31.63%
- Annual Capex/Depreciation for 2022 was -1.23 (a -78.48% decrease from previous year)
- Annual Capex/Depreciation for 2021 was -5.72 (a 197.88% increase from previous year)
- Annual Capex/Depreciation for 2020 was -1.92 (a -13.45% decrease from previous year)
- Twelve month Capex/Depreciation ending September 30, 2023 was -0.08 (a -79.96% decrease compared to previous quarter)
- Twelve month trailing Capex/Depreciation decreased by -93.33% year-over-year
Trailing Capex/Depreciation for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| -0.08 | -0.41 | -0.69 | -1.23 |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex/Depreciation of Absci Corporation
Most recent Capex/Depreciationof ABSI including historical data for past 10 years.Interactive Chart of Capex/Depreciation of Absci Corporation
Absci Corporation Capex/Depreciation for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.08 | -0.05 | -0.07 | – | – |
| 2022 | -0.12 | -1.43 | -1.23 | -2.36 | -1.23 |
| 2021 | -3.01 | -2.53 | -14.78 | -13.37 | -5.72 |
| 2020 | -2.59 | -2.22 | -1.27 | -1.03 | -1.92 |
| 2019 | -2.22 | – | – | – | -2.22 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology